Jump Financial, LLC Vor Biopharma Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.1 $7,929 - $12,460	-11,328 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$1.0 - $2.2 $11,328 - $24,921	11,328 New	11,328 $11,000
Q2 2023 Oct 21, 2024	BUY	$3.09 - $5.33 $25,557 - $44,084	8,271 Added 80.08%	18,600 $57,000
Q2 2023 Aug 07, 2023	BUY	$3.09 - $5.33 $25,557 - $44,084	8,271 Added 80.08%	18,600 $57,000
Q1 2023 Oct 21, 2024	SELL	$4.68 - $6.96 $4,675 - $6,953	-999 Reduced 8.82%	10,329 $55,000
Q1 2023 May 03, 2023	BUY	$4.68 - $6.96 $48,339 - $71,889	10,329 New	10,329 $55,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.